Skip to main content
Premium Trial:

Request an Annual Quote

Almaden Genomics: David Gascoigne

Almaden Genomics, an IBM Research bioinformatics spinoff, has appointed David Gascoigne as CEO. Gascoigne joins the company from Sutherland Global Services where he was head of healthcare analytics. Prior to that he was chief operating officer of GNS Healthcare. He has also served as general manager of analytics services for Iqvia and executive VP of analytics and innovation for Symphony Health; and was a partner in digital analytics with Accenture. He holds an advanced degree in applied statistics from Sheffield University.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.